Top Markets
Coin of the day
Curanex Pharmaceuticals Inc Common Stock Curanex Pharmaceuticals Inc Common Stock

Curanex Pharmaceuticals Inc Common Stock

CURX
Clasificación en acciones #34062
Curanex Pharmaceuticals Inc. is an emerging biopharmaceutical company focused... Curanex Pharmaceuticals Inc. is an emerging biopharmaceutical company focused on identifying, advancing, and bringing to market plant-based medicines to address various inflammatory conditions. Their primary drug candidate, Phyto-N, is currently in development for a broad spectrum of health issues, including but not limited to ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, gout, and acne. Established in 1996 and based in Jericho, New York, the company was formerly known as Fordman Pharma Inc. before adopting its current name in November 2023.
Precio por acción
$0.223
Última sincronización: 2026-08-14
Capitalización bursátil
$6.32M
Cambio (1 día)
1.64%
Cambio (1 año)
-
País
US
Comercio Curanex Pharmaceuticals Inc Common Stock (CURX)

Categoría

EPS de Curanex Pharmaceuticals Inc Common Stock (CURX)
EPS a fecha de 2026 TTM: 0
Según los últimos informes financieros y el precio de las acciones de Curanex Pharmaceuticals Inc Common Stock, el EPS actual de la empresa (TTM) es 0. Al final del año 2026, la empresa tenía un EPS de 0 igual a al EPS de 2026, que fue de 0.
Historial de EPS de Curanex Pharmaceuticals Inc Common Stock desde 2026 hasta 2026
EPS al final de cada año
Año EPS Cambiar
Not enough data for the provided dates.
EPS de empresas similares o competidoras
Empresa EPS Diferencia de EPS País
$17.32 -
US
$27.74 -
NL
- -
CH
- -
KR
$13.70 -
BE